{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:15:40Z","timestamp":1778958940970,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/DTP-FTO\/1489\/2014"],"award-info":[{"award-number":["PTDC\/DTP-FTO\/1489\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/SAU-FCF\/102958\/2008"],"award-info":[{"award-number":["PTDC\/SAU-FCF\/102958\/2008"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SFRH\/BPD\/110001\/2015"],"award-info":[{"award-number":["SFRH\/BPD\/110001\/2015"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SFRH\/BPD\/63746\/2009"],"award-info":[{"award-number":["SFRH\/BPD\/63746\/2009"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","award":["FCOMP-01-0124-FEDER-011079"],"award-info":[{"award-number":["FCOMP-01-0124-FEDER-011079"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000024"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000024"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-016537"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016537"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.toxlet.2017.01.012","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T19:51:03Z","timestamp":1484941863000},"page":"65-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells"],"prefix":"10.1016","volume":"269","author":[{"given":"R.","family":"Feio-Azevedo","sequence":"first","affiliation":[]},{"given":"V.M.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"L.M.","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"P.S.","family":"Branco","sequence":"additional","affiliation":[]},{"given":"F.C.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"M.L.","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"F.","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"J.P.","family":"Capela","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2017.01.012_bib0005","doi-asserted-by":"crossref","first-page":"e19258","DOI":"10.1371\/journal.pone.0019258","article-title":"Methamphetamine inhibits the glucose uptake by human neurons and astrocytes: stabilization by acetyl-L-carnitine","volume":"6","author":"Abdul Muneer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0010","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/cpt1973145870","article-title":"Amphetamine metabolism in amphetamine psychosis","volume":"14","author":"Angg\u00e5rd","year":"1973","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3565(25)04496-9","article-title":"Studies on sympathomimetic amines. ii. The biotrans-formation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-meth-amphetamine","volume":"110","author":"Axelrod","year":"1954","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0020","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/004982599238344","article-title":"Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives","volume":"29","author":"Bach","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00204-013-1120-7","article-title":"The mixture of ecstasy and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations","volume":"88","author":"Barbosa","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.665","article-title":"Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation","volume":"20","author":"Bell","year":"2005","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/mp.2008.90","article-title":"Potential adverse effects of amphetamine treatment on brain and behavior: a review","volume":"14","author":"Berman","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuro.2012.09.005","article-title":"The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons","volume":"34","author":"Capela","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13556210120056544","article-title":"Adaptative response of antioxidant enzymes in different areas of rat brain after repeated d-amphetamine administration","volume":"6","author":"Carvalho","year":"2001","journal-title":"Addict. Biol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00204-012-0815-5","article-title":"Toxicity of amphetamines: an update","volume":"86","author":"Carvalho","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tox.2009.03.012","article-title":"Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes","volume":"260","author":"Costa","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0060","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.2174\/092986711795656081","article-title":"Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases","volume":"18","author":"Costa","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-1759(02)00070-4","article-title":"Regulation and measurement of oxidative stress in apoptosis","volume":"265","author":"Curtin","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.2042-7158.1966.tb07896.x","article-title":"The fate of amphetamine in man and other mammals","volume":"18","author":"Dring","year":"1966","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0075","series-title":"European Drug Report 2016: Trends and Developments","author":"EMCDDA","year":"2016"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.26975","article-title":"Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration","volume":"201","author":"Ellison","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2012.11.015","article-title":"Neurotoxicity of ecstasy and its metabolites in human dopaminergic differentiated SH-SY5Y cells","volume":"216","author":"Ferreira","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0090","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1083\/jcb.136.5.1137","article-title":"Neuroprotective action of cycloheximide involves induction of Bcl-2 and antioxidant pathways","volume":"136","author":"Furukawa","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.lfs.2005.05.103","article-title":"Antioxidant and antiradical activities of L-carnitine","volume":"78","author":"G\u00fcl\u00e7in","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0100","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0024-3205(69)90027-7","article-title":"Tissue concentrations of p-hydroxynorephedrine in rats injected with d-amphetamine: effect of pretreatment with desipramine","volume":"8","author":"Groppetti","year":"1969","journal-title":"Life Sci."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00500043","article-title":"Kinetics and metabolism of amphetamine in the brain of rats of different ages","volume":"291","author":"Honecker","year":"1975","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0110","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1096\/fj.04-2881fje","article-title":"Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway","volume":"19","author":"Krasnova","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0115","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3565(24)38829-9","article-title":"Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine","volume":"296","author":"Kuczenski","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3565(25)31452-7","article-title":"Metabolism of amphetamine after acute and chronic administration to the rat","volume":"207","author":"Kuhn","year":"1978","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0773.1971.tb00579.x","article-title":"Displacement of brain and heart noradrenaline by p-hydroxynorephedrine after administration of p-hydroxyamphetamine","volume":"29","author":"Lewander","year":"1971","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0773.1971.tb00580.x","article-title":"On the presence of p-hydroxynorephedrine in the rat brain and heart in relation to changes in catecholamine levels after administration of amphetamine","volume":"29","author":"Lewander","year":"1971","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0135","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00702-006-0487-5","article-title":"Methylphenidate exerts no neurotoxic, but neuroprotective effects in vitro","volume":"113","author":"Ludolph","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0140","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1399-5618.2012.01046.x","article-title":"Effects of alpha-lipoic acid in an animal model of mania induced by d-amphetamine","volume":"14","author":"Mac\u00eado","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1248\/jhs.53.31","article-title":"Synthesis and cyclic voltammetry studies of 3, 4-methylenedioxymethamphetamine (MDMA) human metabolites","volume":"53","author":"Macedo","year":"2007","journal-title":"J. Health Sci."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0150","doi-asserted-by":"crossref","first-page":"347312","DOI":"10.1155\/2013\/347312","article-title":"Differential effects of methyl-4-phenylpyridinium ion, rotenone, and paraquat on differentiated SH-SY5Y cells","volume":"2013","author":"Martins","year":"2013","journal-title":"J. Toxicol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3181\/00379727-107-26540","article-title":"Effect of D-amphetamine on rat brain noradrenaline and serotonin","volume":"107","author":"McLean","year":"1961","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.neuroscience.2014.07.009","article-title":"Modeling chronic brain exposure to amphetamines using primary rat neuronal cortical cultures","volume":"277","author":"Nogueira","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/138920011796504536","article-title":"L-carnitine-metabolic functions and meaning in humans life","volume":"12","author":"Pekala","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0170","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF03033178","article-title":"Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists","volume":"5","author":"Presgraves","year":"2004","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0175","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6750-5-12","article-title":"A simple technique for quantifying apoptosis in 96-well plates","volume":"5","author":"Ribble","year":"2005","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0006-8993(84)91221-6","article-title":"Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers","volume":"303","author":"Ricaurte","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/jpet.105.087916","article-title":"Amphetamine treatment similar to that used in the treatment of adult attention-deficit\/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates","volume":"315","author":"Ricaurte","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12035-009-8053-4","article-title":"A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters","volume":"39","author":"Robertson","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0195","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1177\/0269881109105563","article-title":"Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells","volume":"24","author":"Schmidt","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0200","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.euroneuro.2013.01.005","article-title":"Monoaminergic dysfunction in recreational users of dexamphetamine","volume":"23","author":"Schouw","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0205","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/npp.2014.301","article-title":"Dopaminergic system dysfunction in recreational dexamphetamine users","volume":"40","author":"Schrantee","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1476-5381.1963.tb01467.x","article-title":"Dopamine-\u03b2-oxidase activity in man, using hydroxyamphetamine as substrate","volume":"20","author":"Sjoerdsma","year":"1963","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0215","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(25)29545-3","article-title":"Effects of amphetamine and its hydroxylated metabolites on central noradrenergic mechanisms","volume":"185","author":"Taylor","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijdevneu.2014.12.001","article-title":"The neurotoxicity of amphetamines during the adolescent period","volume":"41","author":"Teixeira-Gomes","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0225","unstructured":"United Nations Office on Drugs and Crime, World Drug Report 2015 (United Nations publication, Sales No. E.15.XI.6), Vienna, Austria."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.forsciint.2007.03.030","article-title":"Post-mortem cases involving amphetamine-based drugs in the Netherlands: comparison with driving under the influence cases","volume":"170","author":"Verschraagen","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0235","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.bmc.2006.06.006","article-title":"Synthesis and evaluation of uterine relaxant activity for a novel series of substituted p-hydroxyphenylethanolamines","volume":"14","author":"Viswanathan","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.toxlet.2017.01.012_bib0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.30.5.547","article-title":"Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate","volume":"30","author":"Wagner","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0245","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biopsych.2004.06.008","article-title":"Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: a functional magnetic resonance imaging study of blood oxygen level-dependent response","volume":"56","author":"Willson","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0250","first-page":"1086","article-title":"SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease","volume":"123","author":"Xie","year":"2010","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.toxlet.2017.01.012_bib0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2131\/jts.22.65","article-title":"Deamination of amphetamines by cytochromes P450: studies on substrate specificity and regioselectivity with microsomes and purified CYP2C subfamily isozymes","volume":"22","author":"Yamada","year":"1997","journal-title":"J. Toxicol. Sci."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427417300127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427417300127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T17:59:13Z","timestamp":1749923953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427417300127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":51,"alternative-id":["S0378427417300127"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.01.012","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}